FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147134417> ?p ?o ?g. }

• W2147134417 endingPage "2772" @default.
• W2147134417 startingPage "2765" @default.
• W2147134417 abstract "Purpose The role of antiviral prophylaxis in preventing hepatitis B virus (HBV) reactivation before rituximab-based chemotherapy in patients with lymphoma and resolved hepatitis B is unclear. Patients and Methods Eighty patients with CD20 + lymphoma and resolved hepatitis B were randomly assigned to receive either prophylactic entecavir (ETV) before chemotherapy to 3 months after completing chemotherapy (ETV prophylactic group, n = 41) or to receive therapeutic ETV at the time of HBV reactivation and hepatitis B surface antigen (HBsAg) reverse seroconversion since chemotherapy (control group, n = 39). Results Fifty-eight patients (72.5%) were positive for hepatitis B surface antibody, and HBV DNA was undetectable in 50 patients (62.5%). During a mean 18-month follow-up period, one patient (2.4%) in the ETV prophylactic group and seven patients (17.9%) in the control group developed HBV reactivation (P = .027). The cumulative HBV reactivation rates at months 6, 12, and 18 after chemotherapy were 8%, 11.2%, and 25.9%, respectively, in the control group, and 0%, 0%, and 4.3% in the ETV prophylactic group (P = .019). Four patients (50%) in the control group had HBsAg reverse seroconversion after HBV reactivation. The cumulative HBsAg reverse seroconversion rates at months 6, 12, and 18 since chemotherapy were 0%, 6.4%, and 16.3% in the control group, respectively, which were significantly higher than those in the ETV prophylactic group (P = .032). Patients with detectable or undetectable viral load could develop HBV reactivation and HBsAg reverse seroconversion. Conclusion Undetectable HBV viral load before chemotherapy did not confer reactivation-free status. Antiviral prophylaxis can potentially prevent rituximab-associated HBV reactivation in patients with lymphoma and resolved hepatitis B." @default.
• W2147134417 created "2016-06-24" @default.
• W2147134417 creator A5001233509 @default.
• W2147134417 creator A5005562046 @default.
• W2147134417 creator A5006351473 @default.
• W2147134417 creator A5015287747 @default.
• W2147134417 creator A5015767105 @default.
• W2147134417 creator A5029256082 @default.
• W2147134417 creator A5039836090 @default.
• W2147134417 creator A5046499374 @default.
• W2147134417 creator A5050755783 @default.
• W2147134417 creator A5069854148 @default.
• W2147134417 creator A5084631637 @default.
• W2147134417 creator A5091380143 @default.
• W2147134417 date "2013-08-01" @default.
• W2147134417 modified "2023-10-14" @default.
• W2147134417 title "Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B" @default.
• W2147134417 cites W1977302908 @default.
• W2147134417 cites W2000635340 @default.
• W2147134417 cites W2005790431 @default.
• W2147134417 cites W2007439575 @default.
• W2147134417 cites W2012007321 @default.
• W2147134417 cites W2020511975 @default.
• W2147134417 cites W2025722002 @default.
• W2147134417 cites W2031317669 @default.
• W2147134417 cites W2034440827 @default.
• W2147134417 cites W2044951291 @default.
• W2147134417 cites W2051055769 @default.
• W2147134417 cites W2085445630 @default.
• W2147134417 cites W2085997970 @default.
• W2147134417 cites W2087564721 @default.
• W2147134417 cites W2091556965 @default.
• W2147134417 cites W2095058829 @default.
• W2147134417 cites W2096966773 @default.
• W2147134417 cites W2125474736 @default.
• W2147134417 cites W2126234152 @default.
• W2147134417 cites W2133253108 @default.
• W2147134417 cites W2138955583 @default.
• W2147134417 cites W2155791431 @default.
• W2147134417 cites W2161758234 @default.
• W2147134417 cites W2164785014 @default.
• W2147134417 cites W2168926834 @default.
• W2147134417 cites W2943463865 @default.
• W2147134417 cites W3030265267 @default.
• W2147134417 cites W4211026375 @default.
• W2147134417 doi "https://doi.org/10.1200/jco.2012.48.5938" @default.
• W2147134417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23775967" @default.
• W2147134417 hasPublicationYear "2013" @default.
• W2147134417 type Work @default.
• W2147134417 sameAs 2147134417 @default.
• W2147134417 citedByCount "286" @default.
• W2147134417 countsByYear W21471344172013 @default.
• W2147134417 countsByYear W21471344172014 @default.
• W2147134417 countsByYear W21471344172015 @default.
• W2147134417 countsByYear W21471344172016 @default.
• W2147134417 countsByYear W21471344172017 @default.
• W2147134417 countsByYear W21471344172018 @default.
• W2147134417 countsByYear W21471344172019 @default.
• W2147134417 countsByYear W21471344172020 @default.
• W2147134417 countsByYear W21471344172021 @default.
• W2147134417 countsByYear W21471344172022 @default.
• W2147134417 countsByYear W21471344172023 @default.
• W2147134417 crossrefType "journal-article" @default.
• W2147134417 hasAuthorship W2147134417A5001233509 @default.
• W2147134417 hasAuthorship W2147134417A5005562046 @default.
• W2147134417 hasAuthorship W2147134417A5006351473 @default.
• W2147134417 hasAuthorship W2147134417A5015287747 @default.
• W2147134417 hasAuthorship W2147134417A5015767105 @default.
• W2147134417 hasAuthorship W2147134417A5029256082 @default.
• W2147134417 hasAuthorship W2147134417A5039836090 @default.
• W2147134417 hasAuthorship W2147134417A5046499374 @default.
• W2147134417 hasAuthorship W2147134417A5050755783 @default.
• W2147134417 hasAuthorship W2147134417A5069854148 @default.
• W2147134417 hasAuthorship W2147134417A5084631637 @default.
• W2147134417 hasAuthorship W2147134417A5091380143 @default.
• W2147134417 hasBestOaLocation W21471344171 @default.
• W2147134417 hasConcept C126322002 @default.
• W2147134417 hasConcept C159047783 @default.
• W2147134417 hasConcept C159654299 @default.
• W2147134417 hasConcept C203014093 @default.
• W2147134417 hasConcept C2522874641 @default.
• W2147134417 hasConcept C2776175608 @default.
• W2147134417 hasConcept C2776694085 @default.
• W2147134417 hasConcept C2777382497 @default.
• W2147134417 hasConcept C2777410769 @default.
• W2147134417 hasConcept C2777451964 @default.
• W2147134417 hasConcept C2777869810 @default.
• W2147134417 hasConcept C2779338263 @default.
• W2147134417 hasConcept C2780593183 @default.
• W2147134417 hasConcept C2780653079 @default.
• W2147134417 hasConcept C71924100 @default.
• W2147134417 hasConcept C90924648 @default.
• W2147134417 hasConceptScore W2147134417C126322002 @default.
• W2147134417 hasConceptScore W2147134417C159047783 @default.
• W2147134417 hasConceptScore W2147134417C159654299 @default.
• W2147134417 hasConceptScore W2147134417C203014093 @default.
• W2147134417 hasConceptScore W2147134417C2522874641 @default.
• W2147134417 hasConceptScore W2147134417C2776175608 @default.

• next